Bayer CropScience logo

Bayer CropScience

BAYERCROP NSE
₹3,592.40 53.50 (1.51%)
Market Cap
₹16,145 Cr
P/E
22.05

Key Fundamentals

SmallcapPesticides & AgrochemicalsChemicals
Market Cap
₹16,145 Cr
P/E (TTM)
22.05
EBITDA
₹969 Cr
Return on Equity
23.24%
Debt to Equity
0.03
Book Value
₹659.90
EPS (TTM)
₹162.90
52W High
₹5,149.90
52W Low
₹3,366.30

Price-based figures as of 13 Oct 2026, 15:29 IST · EPS basis: Standalone · TTM

Peer Comparison

Commodities › Chemicals › Pesticides & Agrochemicals

UPL
₹524.7021.9144,294 Cr1.281.23%5.38%10.85%53,683 Cr2,323 Cr
PI Industries
₹2,130.0027.7332,316 Cr2.880.71%11.76%14.68%6,914 Cr1,164 Cr
Sumitomo Chemical
₹414.2535.6520,677 Cr6.100.31%16.00%20.98%3,427 Cr581 Cr
Bayer CropScience (this company)
₹3,592.4022.0516,145 Cr5.444.30%23.24%27.93%5,761 Cr733 Cr
Sharda Cropchem
₹721.2510.396,507 Cr2.072.07%21.71%25.26%5,464 Cr626 Cr
Rallis
₹200.0518.173,890 Cr1.901.51%9.68%12.75%2,631 Cr214 Cr
Dhanuka Agritech
₹866.7014.553,864 Cr2.300.23%21.17%27.37%2,071 Cr268 Cr
NACL Industries
₹128.12241.743,001 Cr4.400.54%0.67%7.82%1,523 Cr13 Cr
Bhagiradha Chemicals & Industries
₹221.66104.562,874 Cr4.120.07%2.60%4.41%611 Cr28 Cr
GSP Crop Science
₹476.6519.952,217 Cr2.870.21%12.30%20.16%1,546 Cr98 Cr
Median 10 companies₹500.6821.985,199 Cr2.880.63%12.03%17.42%3,029 Cr425 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-12
v2.0.0
53 Average
Overall score
Data confidence 100/100

Category scores

Quality Strong 81
Returns, margins, earnings quality 22%
Valuation Good 60
Cheap vs sector & own history 24%
Growth Poor 13
Sales & profit trajectory 9%
Financial Health Strong 79
Solvency, leverage, coverage 9%
Momentum Poor 12
Trend strength, vol-adjusted 12%
Ownership Average 49
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

5
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is providing a good dividend yield of 4.27%.
  • Company has been maintaining a healthy dividend payout of 93.8%
  • Company's working capital requirements have reduced from 74.0 days to 56.1 days

Weaknesses

1
  • The company has delivered a poor sales growth of 5.90% over past five years.

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
3
Neutral
5
Bullish
1

Overall

BearishNeutralBullish

Bearish

Bearish
13
Neutral
5
Bullish
1

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0
Analyst Rating
Based on 7 analysts
BUY SHARE57%

4 of 7 analysts rate Buy, 3 Hold, 0 Sell.

Updated 13 Oct 2026

BUY
4
57.1%
HOLD
3
42.9%
SELL
0
0%

Growth Rate

Revenue Growth
3.16% higher than 3Y

change over 1 year

Net Income Growth
21.34% higher than 3Y

change over 1 year

Cash Flow Change
312%

change over 1 year

EBITDA Margin Change
16.03%

change over 1 year Operating margin 20% · Jun 2026

AI Analysis — Bull vs Bear

Figures as of 8 Oct 2026
AI opinion · based on fundamentals
Risk medium

As of the 2026-10-08 close, Bayer CropScience Ltd traded at ₹3,381.6, giving a market cap of ₹15,197.62 Cr, a TTM P/E of 20.76 and a P/B of 5.12. The price was 0.46% above its 52-week low of ₹3,366.3 and about 34.3% below its 52-week high of ₹5,149.9. The balance sheet is nearly debt-free (D/E 0.03), returns are high (ROE 23.24%, ROCE 27.93%) and the dividend yield is 4.3%. Against that, sales growth is weak: -3% TTM and 3% compounded over three years.

Bull Case 7
  • The balance sheet is nearly debt-free, with a debt-to-equity ratio of 0.03 as of 2026-10-08, and the company has reduced its debt. This leaves little financial risk and room to absorb a weak agri season.
  • Capital efficiency is high and steady: ROE was 23.24% and ROCE was 27.93% as of 2026-10-08. ROE has stayed in a 21%-24% band over the 3, 5 and 10-year periods, which points to lasting returns over time.
  • The dividend yield was 4.3% as of 2026-10-08, backed by a 93.8% payout ratio. That is a high cash return for an Indian chemicals and agrochemicals company.
  • TTM profit grew 24% while TTM sales fell 3%. This points to better margins and cost control, and TTM EPS reached ₹162.9.
  • Working capital needs fell from 74.0 days to 56.1 days, an improvement of about 18 days. This frees up cash and lowers exposure to channel credit risk.
  • The P/E has come down to 20.76 on a TTM basis as of 2026-10-08, with an earnings yield of about 4.8%. The stock traded about 34.3% below its 52-week high of ₹5,149.9 and close to its 52-week low of ₹3,366.3, so much of the recent pessimism may already be in the price.
  • Over the long run, sales have compounded at 7% and profit at 8% over 10 years. This shows the business has grown through several agri cycles.
Bear Case 7
  • Revenue momentum is weak: TTM sales fell 3%, 3-year compounded sales growth is only 3%, and 5-year growth is 5.9-6%. All of these lag what a growth-oriented agrochemical business would normally deliver.
  • Profit growth over three years has been almost flat at a 1% CAGR. This suggests the 24% TTM profit jump may be a rebound from a low base or a margin effect, not a lasting trend.
  • Shareholders have lost money over every period measured. The stock CAGR is -30% over 1 year, -13% over 3 years, -8% over 5 years and -2% over 10 years.
  • The price trend was weak as of 2026-10-08. The stock was just 0.46% above its 52-week low of ₹3,366.3 and about 34.3% below its 52-week high of ₹5,149.9.
  • A 93.8% dividend payout leaves little earnings to reinvest in R&D, new product launches or capacity. Growth then depends on the parent company's product pipeline, and the 4.3% yield depends on earnings holding up.
  • At a P/B of 5.12 as of 2026-10-08, the stock trades at a large premium to book value per share of about ₹660. That premium may be hard to justify for a business with 3% 3-year sales growth.
  • Margin-led profit growth (TTM profit +24% on TTM sales -3%) may reverse if raw material costs, pricing pressure from generics, or monsoon-driven demand moves against the company. Long-term profit CAGR is only 7-8% over 5-10 years.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

6d ago
Neutral 1
  • Ravi Kirpalani independent director appointment Sep 8

    Bayer CropScience is asking shareholders to approve Mr. Ravi Moti Kirpalani as an independent director by postal ballot. Voting opens on September 14, 2026 and closes on October 13, 2026.

TL;DR: The only recent news for Bayer CropScience is a routine board appointment. It is a governance matter and has no clear effect on earnings, margins or demand. With a single neutral item, the news gives no signal on whether the trend is improving or worsening, and there are no new risks or catalysts. Investors should watch the October 13, 2026 ballot result and, more importantly, the upcoming quarterly results, kharif-to-rabi season demand, monsoon effects on agrochemical volumes, and any pricing or regulatory changes for crop protection products.

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹968 Cr −0.1% vs FY26
Reported High Mean Low

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1,740
1,617
955
792
1,631
1,738
1,057
1,046
1,915
1,553
1,106
1,101
1,835
Expenses
1,315
1,312
827
695
1,317
1,554
1,037
876
1,566
1,348
989
898
1,467
Operating Profit
425
305
128
97
314
184
20
171
348
205
117
203
368
OPM %
24%
19%
13%
12%
19%
11%
1.9%
16%
18%
13%
11%
18%
20%
Other Income
21
16
15
29
27
24
32
37
19
14
16
47
89
Interest
8
4
3
5
4
3
4
6
5
4
5
6
4
Depreciation
31
12
15
16
22
14
15
34
27
14
15
38
50
PBT
406
306
124
105
316
190
34
168
335
200
113
206
402
Tax %
19%
27%
25%
9%
20%
28%
-2%
15%
17%
24%
15%
21%
20%
Net Profit
328
223
93
96
254
136
34
143
279
153
96
162
322
EPS (₹)
73.09
49.6
20.72
21.36
56.56
30.33
7.61
31.89
62.01
33.98
21.29
36.07
71.56
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3,660
2,769
2,803
2,710
3,167
3,609
4,261
4,734
5,140
5,106
5,473
5,675
5,595
Expenses
3,144
2,334
2,389
2,300
2,684
2,883
3,450
3,923
4,216
4,147
4,783
4,801
4,702
Operating Profit
516
435
414
410
483
726
812
812
924
959
691
874
893
OPM %
14%
16%
15%
15%
15%
20%
19%
17%
18%
19%
13%
15%
16%
Other Income
88
82
70
39
51
-64
69
112
168
76
118
95
165
Interest
5
10
7
11
10
14
13
13
22
20
17
20
19
Depreciation
25
25
29
33
44
65
74
64
80
74
85
94
117
PBT
574
482
448
404
480
583
794
847
990
941
707
855
922
Tax %
33%
35%
35%
26%
30%
19%
38%
24%
23%
21%
20%
19%
—
Net Profit
383
315
291
300
337
474
493
645
758
740
568
689
732
EPS (₹)
105
89.13
82.31
87.41
98.18
106
110
144
169
165
126
153
163
Div. Payout %
20%
19%
21%
21%
18%
24%
105%
104%
77%
85%
99%
98%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
37
35
35
34
34
45
45
45
45
45
45
45
Reserves
1,996
1,804
2,021
1,744
2,205
2,528
2,505
2,479
2,667
2,804
2,806
2,921
Borrowings
0
0
0
0
0
2
26
86
74
47
105
82
Other Liabilities
740
597
769
756
1,310
1,262
1,663
1,742
1,893
1,701
2,290
2,652
Total Liabilities
2,773
2,437
2,825
2,535
3,549
3,836
4,239
4,353
4,679
4,597
5,246
5,699
Fixed Assets
322
290
342
334
440
468
425
468
462
414
470
458
CWIP
1
17
24
36
47
56
76
98
109
119
119
127
Investments
29
68
50
0
0
41
52
38
41
54
35
57
Other Assets
2,422
2,062
2,410
2,164
3,062
3,270
3,686
3,749
4,066
4,010
4,622
5,056
Total Assets
2,773
2,437
2,825
2,535
3,549
3,836
4,239
4,353
4,679
4,597
5,246
5,699
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
200
206
157
121
433
666
687
216
609
952
262
1,078
Investing
485
16
-8
38
-113
-29
7
64
83
0
86
72
Financing
-42
-590
-73
-581
-158
-148
-556
-703
-613
-656
-619
-624
Net Cash Flow
644
-367
76
-421
162
489
138
-424
79
296
-272
527
Free Cash Flow
297
170
108
80
378
638
656
168
537
912
222
1,014
CFO/OP
76
86
74
53
132
110
105
59
92
113
61
142
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
57
53
72
89
81
73
65
77
69
69
63
72
Inventory Days
85
169
178
175
294
206
226
235
268
222
319
289
Days Payable
40
52
67
67
164
101
142
127
129
87
148
167
Cash Conversion Cycle
102
171
184
197
211
177
149
185
208
204
234
193
Working Capital Days
53
92
104
134
116
77
61
84
86
78
88
56
ROCE %
31%
25%
23%
22%
25%
30%
31%
31%
34%
34%
25%
29%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bayer CropScience insights

62 extracted metrics + investor summaries across FY11–FY27.

Log in — free

Shareholding Pattern

FIIs3.97%Promot.71.43%Others4.33%Public8.63%DIIs11.64%As ofJun 2026

Documents

Frequently Asked Questions about Bayer CropScience

What does Bayer CropScience Ltd do?
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
Where is Bayer CropScience Ltd (BAYERCROP) listed?
Bayer CropScience Ltd trades as BAYERCROP on the NSE and under code 506285 on the BSE.
Which sector does Bayer CropScience Ltd belong to?
Bayer CropScience Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Bayer CropScience Ltd?
Bayer CropScience Ltd has a market capitalisation of ₹16,145 Cr as of 13 Oct 2026, which places it in the Mid Cap band.
What is the PE ratio of Bayer CropScience Ltd?
Bayer CropScience Ltd trades at a PE ratio of 22.05 as of 13 Oct 2026, on earnings per share of ₹162.9, against a book value of ₹659.9 per share.
What is the 52-week high and low of Bayer CropScience Ltd?
Over the last 52 weeks Bayer CropScience Ltd has traded between ₹3,366.3 and ₹5,149.9 as of 13 Oct 2026.
Does Bayer CropScience Ltd pay dividends?
Bayer CropScience Ltd has a dividend yield of 4.24%.
What is the Return on Equity (ROE) of Bayer CropScience Ltd?
Bayer CropScience Ltd reported a return on equity of 23.24%. Its debt-to-equity ratio is 0.03.

Company Information

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

Website bayer.in
CEO Mr. Simon-Thorsten Wiebusch
Employees 1,169
Listed 2010-01-08
Face Value ₹ 10
Shares Outstanding 4,49,42,092

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BAYERCROP.md for Bayer CropScience Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List